Praziquantel-loaded PLGA nanoparticles: Preparation and characterization

Journal of Microencapsulation

Volumn 22, Issue 1, 2005, Pages 13-24

  Mainardes, Rubiana Mara ^a   Evangelista, R C ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Controlled release; Nanoparticles; PLGA; Praziquantel

Indexed keywords

ACETIC ACID ETHYL ESTER; DICHLOROMETHANE; NANOPARTICLE; ORGANIC SOLVENT; POLYGLACTIN; PRAZIQUANTEL;

ARTICLE; CHEMICAL INTERACTION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG RELEASE; EMULSION; EVAPORATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTERMETHOD COMPARISON; MICROENCAPSULATION; PARTICLE SIZE;

ACETATES; BIOCOMPATIBLE MATERIALS; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; LACTIC ACID; METHYLENE CHLORIDE; MICROSCOPY, ELECTRON, SCANNING; NANOSTRUCTURES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; PRAZIQUANTEL; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 20144364881     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.1080/02652040400026285     Document Type: Article

References (25)

1. Allemann E, Leroux JC, Gurny R. 1998. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. Advanced Drug Delivery Reviews 34:171-189.
2. Anderson JM, Shive MS. 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Delivery Reviews 28:5-24.
3. Becket G, Schep LJ, Tan MY. 1999. Improvement of the in vitro dissolution of praziquantel by complexation with α-, β- and γ-ciclodextrins. International Journal of Pharmaceutics 179:65-71.
4. Binrbaum DT, Kosmala JD, Henthorn DB, Brannon-Peppas L. 2000. Controlled release of β-estardiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release. Journal of Controlled Release 65:375-387.
5. Brannon-Peppas L. 1995. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. International Journal of Pharmaceutics 116:1-9.
6. Burkersroda FV, Schedl L, Göpferich A. 2002. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials 23:221-231.
7. Chorny M, Fishbein I, Danenberg HD, Golomb G. 2002. Lipophilic drug loaded nanospheres prepared by nanoparecipitation: effect of formulating variables on size, drug recovery and release kinetics. Journal of Controlled Release 83:389-400.
8. El-Arini SK, Leuenberger H. 1998. Dissolution properties of praziquantel-PVP systems. Pharmaceutica Acta Helvitae 73:89-94.
9. Feng S, Huang G. 2002. Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers. Journal of Controlled Release 71:53-69.
10. Freytag T, Dashevsky A, Tillman L, Hardee GE, Bodmeier R. 2000. Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres. Journal of Controlled Release 69:197-207.
11. Görner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. 1999. Lidocaine-loaded biodegradable nanospheres I. Optimization of the drug incorporation into the polymer matrix. Journal of Controlled Release 57:59-68.
12. Hans ML, Lowman AM. 2002. Biodegradable nanoparticles for drug delivery and targeting. Current Opinion in Science 6:319-327.
13. Jain RA. 2000. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials 21:2475-2490.
14. Jeon HJ, Jeong YL, Jang MK, Park YH, Nah JW. 2000. Effect of solvent on the preparation of surfactant-free poly (D,L-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. International Journal of Pharmaceutics 207:99-108.
15. Mainardes RM, Silva LP. 2004. Drug delivery systems: past, present and future. Current Drug Targets 5:389-406.
16. Mu L, Feng SS. 2002. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®). Journal of Controlled Release 80:129-144.
17. Panyam J, Labhasetwar V. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Reviews 55:329-347.
18. Park TG. 1995. Degradation of poly (lactide-co-glycolide acid) microspheres: effect of copolymer composition. Biomaterials 16:1123-1130.
19. Sah H. 1997. Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on characteristics of PLGA microspheres. Journal of Controlled Release 47:233-245.
20. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. 2002. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Journal of Controlled Release 82:105-114.
21. Schepmann D, Blaschke G. 2001. Isolation and identification of 8-hydroxypraziquantel as a metabolite of the antischistosomal drug praziquantel. Journal of Pharmaceutical and Biomedical Analysis 26:791-799.
22. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release 70:1-20.
23. Uhrich KE, Cannizzaro SM, Langer RS, Shakeshelf KM. 1999. Polymeric systems for controlled drug release. Chemical Reviews 99:3181-3198.
24. Vandervoort J, Ludwig A. 2002. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. International Journal of Pharmaceutics 238:77-92.
25. Vert M, Schwach G, Engel R, Coudane J. 1998. Something new in the field of PLA/GA bioresorbable polymers? Journal of Controlled Release 53:85-92.